Quantcast

Phase II Anti-NYESO-1 immunotherapy trial at NIH


#1

For those who are looking for a trial right now, you should check whether you may be eligible for the following:

http://www.clinicaltrials.gov/ct2/show/NCT01967823

In the initial trial, 4 out of 6 synovial sarcoma patients responded:

http://jco.ascopubs.org/content/29/7/917

In this trial, the method used to produce the anti-NYESO-1 is slightly different and may lead to even better results.

As with previous trial, patients must be HLA-A*0201 positive :-(


#2

Thank you for posting this, Elodie. Good information.